Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)
A Pharmacokinetic Crossover Comparison Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)
1 other identifier
interventional
20
1 country
1
Brief Summary
This clinical study is designed to evaluate difference in the AUC of the absorption of Multivitamin and minerals defined in the protocol
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2017
CompletedFirst Posted
Study publicly available on registry
May 9, 2017
CompletedStudy Start
First participant enrolled
May 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedSeptember 26, 2024
September 1, 2024
1 month
May 6, 2017
September 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mean fractional absorption
A comparison of mean fractional absorption of the two Multivitamin mineral formulations (gel vs. tablet/capsule).
6 hours
Secondary Outcomes (1)
Absorption rate
6 hours
Study Arms (2)
Tablet
ACTIVE COMPARATORThe tablet/capsule will be administered as a single dose of Multivitamins in tablet after 12 hours of fasting. The participants will be monitored during 6 hours for the level of minerals and Multivitamin minerals in the blood, adverse events and vital signs. The results will be used for the AUC calculation of the absorption in order to compare with the Gel administration absorption.
Gel
ACTIVE COMPARATORThe gel will be administrated to the same group of patients in the single dose of Multivitamins in gel after 12 hours of fasting. The participants will be monitored during 6 hours for the level of minerals and Multivitamin minerals in the blood, adverse events and vital signs. The results will be used for the AUC calculation of the absorption in order to compare with the Tablet administration absorption.
Interventions
After the study product administration blood tests will be performed in order to calculate the AUC for each mineral and vitamin - Vit A Vit E Folic Acid Vit C Calcium Magnesium After the washout period, the same procedure will be done for the additional formulation of the multivitamins.
Eligibility Criteria
You may qualify if:
- Healthy male or female and aged 18-65 years
- BMI - 19-24
- Subject is not pregnant and is not nursing
- Signed Informed Consent Form
You may not qualify if:
- Current use of multivitamin or mineral complexes (washout of 4 days before Visit 2 is permitted)
- Participants with known vitamins or mineral deficiencies
- Diabetes Type II
- Smoking
- Subjects who have undergone surgery within the last 3 months.
- Subjects with a clinically significant (during last 3 months) infectious, immune-mediated or active malignant disease.
- Subjects who are receiving an elemental diet or parenteral nutrition.
- Subjects who are treated with insulin.
- Women with childbearing potential unless surgically sterile or using adequate contraception (either IUD, oral or Depo-provera contraceptive, or barrier plus spermicide); pregnant or breastfeeding mothers.
- Subjects who will be unavailable for the duration of the trial, who are unlikely to be compliant with the protocol, or who are felt to be unsuitable by the Investigator for any other reason.
- Known sensitivity to any ingredients in the study product
- History of addiction or drug abuse
- Alcoholic regular use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Galilee CBRlead
Study Sites (1)
Israel
Tel Aviv, Central District, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2017
First Posted
May 9, 2017
Study Start
May 9, 2017
Primary Completion
June 10, 2017
Study Completion
July 1, 2017
Last Updated
September 26, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
The study results will be published.